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reversible cellular aggregation  
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We report the synthesis of two simple copolymers that induce 
rapid cell aggregation within minutes in a fully reversible manner. 
The polymers can act as self-supporting “cellular glues” or as 
“drivers” of 3D cell spheroids/aggregates formation at minute 
concentrations.  
The interaction of cells with the outer environment is primarily 
governed by numerous signalling cascades occurring on the 
cell membrane via ligand-receptor interactions, which 
determine vital processes of the life-cycle of cells including 
differentiation, migration, mitosis, and apoptosis signalling.
1
 
Hence, the cell membrane is arguably the most important 
cellular organelle to probe and direct specific cellular functions 
for therapeutic and research purposes. 
 Cell surface remodelling (CSR) has emerged as a powerful 
approach to control numerous biological (and often un-
natural) functionalities of cells including protection from the 
immune system, cryo-preservation, cell immobilization and 
encapsulation, biopatterning, receptor targeting, as well as 
three-dimensional (3D) microtissue fabrication and organ 
transplantation.
2-4
 In recent years, various (bio-)chemical 
approaches have been reported to functionalize and/or 
derivatize the cell membrane with various components 
including nucleic acids,
5-7
 peptides,
8
 synthetic polymers
9-11
 and 
nanoparticles
12-15
 for cell therapy. CSR is particularly useful in 
the construction of 3D cell/tumour spheroids, and cell-
biomaterial ensembles for tissue engineering applications as 
the concentration of the synthetic component, i.e. the 
biomaterial, is minute and hence the possible cytotoxic or 
immune responses are minimised. Current cell aggregation 
methods via CSR include direct cell membrane biotinylation,
16-
19
 covalent crosslinking,
20, 21
 and polyelectrolyte
22-24
 or ionic 
mediated cell aggregation.
25-27
 The further development of 
such biomaterial-cellular ensembles at the nanoscale is of 
paramount importance in order to mimic the mechanical, 
biochemical and interaction cues that occur in the 
physiological setting.
28
 
In the present work, we report on two simple cell membrane 
interacting polymers that induce and control cell aggregation 
cascades in a fully reversible manner (Fig. 1). 
 Polymer P1 was synthesized by free radical polymerization 
(FRP) of N-vinylpyrrolidone (NVP) acting as a water-soluble 
element, and 3-(acrylamido)phenylboronic acid (APBA) as a 
cis-diol reacting moiety targeting cell membrane glycoprotein 
residues via covalent (but reversible) boronate ester bonds.
29
 
The Mn of P1 was determined by size exclusion 
chromatography (SEC) to be 14100 Da; 
1
H nuclear magnetic 
resonance (NMR) was used to determine the relative 
monomer feed composition of the two monomers on the final 
polymer, which was found to be 99.5:0.5 (NVP:APBA) (ESI, 
Table S1 and Fig. S1). 
 Polymer P2, also synthesized by FRP, is a copolymer of 
di(ethylene glycol) methyl ether methacrylate (DEGMA), which 
acts as a thermoresponsive element,
30, 31
 and N-
hydroxysuccinimide methacrylate (NHS-MA) acting as a 
targeting motif of free primary amino groups on membrane 
proteins
32
 (i.e. lysine residues) via covalent amide bond 
formation. The Mn of P2 was found to be 29800 Da by SEC; the 
ratio of the two monomers on the final polymer was 
determined by 
1
H NMR (Table S1 and Fig. S2) and was found to 
be 99:1 (DEGMA:NHS-MA). P2 had a lower critical solution 
temperature (LCST) onset at sub-cell culture conditions (ca. 
14
o
C) to enable rapid cell aggregates formation even at room 
temperature. 
 Both copolymers were found to induce rapid cell 
aggregation within minutes at relatively low concentrations in 
complete culture media that was fully reversible, albeit with 
distinct de-aggregation mechanisms. Upon mixing with human 
dermal fibroblasts (HDF), P1 triggered rapid formation of cell 
aggregates at relatively low concentrations (200 μg/mL) due to 
the inter-cellular crosslinking of neighbouring cells via diol-
boronate ester formation with cell surface glycoproteins (e.g. 
sialic acid rich moieties), as shown in Fig. 2(a) and movieS1 
(ESI). It should be noted that although the optimum pH for the 
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Fig. 1 Representative phase-contrast microscopy images of cell aggregates formation in presence of (a) P1 and (b) P2 (200 μg/mL) over time with HDF (scale bars = 1 mm). 
formation of diol-boronate esters is close to 8 (the pKa of 
boronic acid is 8.6
33
), at physiological conditions, there is still 
sufficient amount of ionisable boronic acid groups (ca. 6% of 
the total boronate moieties
34
) that bind to cis-diols present on 
the cell membrane at pH 7.4. One approach to further improve 
the rate of boronate ester formation would be the 
introduction of cationic groups on the polymer backbone in 
close proximity with the boronic acid to reduce the optimum 
pH close to the physiological.
35
 Although this could be a 
promising approach, the cationic nature of the polymer would 
trigger coulombic attraction of the polymer and the anionic 
cell membrane, and hence the specificity of the system would 
be potentially compromise. 
 In order to probe the specificity of the interaction of the 
polymer-bound boronic acid with cell membrane diol-rich 
carbohydrate residues, a competition assay was performed by 
addition of increasing amounts of glucose in the culture 
medium (Fig. 3(a)). It was observed that a gradual increase of 
the free glucose concentration resulted in a gradual reduction 
of the average size of the cell aggregates up to a critical point 
above which no aggregates could be observed (at 0.01 mΜ 
glucose). Additional control experiments with APBA-free 
polymers were conducted where no cell aggregates were 
observed under the same experimental conditions (Fig. S5(a)). 
 In a similar procedure, P2 was rapidly installed on the cell 
membrane via amide coupling with free amino groups of 
membrane proteins
11
 by simple mixing with the cells in 
complete medium. Intercellular-type aggregation was quickly 
observed owing to the hydrophobic interactions of the DEGMA 
residues above the polymers’ LCST (Fig. 2(b), movieS2 and Fig. 
S4, ESI). The macroscopic cell aggregation process was found 
to be fully reversible by simple lowering of the temperature 
Fig. 2 Illustration of the macromolecular cell surface modification concept with copolymers P1 and P2. P1 induces cell aggregation through inter-cellular diol-boronate ester 
formation that can be reversed by the addition of diol-rich compounds such as glucose; P2 promotes cell aggregation by covalent anchoring on the cell membrane and 
subsequent formation of cell aggregates due to the thermoresponsive type coil-to-globule phase transition of the polymer above the LCST. 
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below the polymer’s LCST followed by gentle shaking of the 
cell culture well plate. Interestingly, it was possible to perform 
a full thermal cycle in order to demonstrate the reversibility of 
the cell aggregation process without compromising cell 
viability (Fig. 3(b)). Various control experiments were also 
conducted to probe the specificity of the coil-to-globule 
transition of P2 on the cell aggregates formation; a 
poly(DEGMA) homopolymer (without the NHS residue) was 
used as a control where, indeed, we observed the absence of 
cell aggregates under the same experimental conditions (Fig. 
S5(b)). In a second control experiment, a scramble non-
thermoresponsive poly(ethylene glycol) (PEG, Mn 1500) 
polymer was used to eliminate the possibility of viscosity-
triggered type of cell aggregation that has been observed in 
erythrocytes cultures upon addition of PEG based polymers
36
 
(Fig. S5(c)). Therefore, it is concluded that the mechanism of 
cell aggregation is derived from the covalent anchoring of P2 
on the cell membrane concerted by temperature modulated 
coil-to-globule polymer transition that macroscopically drives 
the cell aggregation process. 
 In order to demonstrate the generic nature of the 
proposed aggregation mechanisms for both polymers, we 
performed the same sets of experiments on a model lung 
cancer (A549) cell line. Again, both polymers induced rapid 
aggregates formation at similar rates as observed in the case 
of the HDF cell line (Fig. S6). 
 Finally, to visually monitor the presence of the polymers on 
the cell membrane, we synthesized fluorescent polymer 
derivatives of P1 and P2 by incorporating fluorescein 
methacrylate tags on the polymers’ backbone (see ESI). The 
cells appeared with a characteristic green fluorescent shell in 
the non-adherent state upon mixing with either P1 or P2, 
proving the direct interaction of the polymers with the cells’ 
membrane (Fig. 4(a) and (b)). 
 We then sought to quantify the rate of the cell aggregates 
formation for P1 and P2 with time; the cell aggregates were 
found to increase in a non-linear rate with time, with relatively 
fast rates of aggregation for both polymers in the first 20 
minutes followed by lower rates until the aggregates were 
completed at about 60 minutes (Fig. 4(c)). This result is further 
corroborated by the time-lapsed images (Fig. S4, Fig. S6 and 
movieS1 and movieS2, ESI) where it is observed that the 
aggregates are formed by the initial growth of small “cell 
islands” consisting of a few cells which aggregate together to 
form larger clusters.  
 Furthermore, no toxicity was observed for both polymers 
in HDF after 24 and 48 hours period even at high polymer 
concentrations (up to 500 μg/mL) (Fig. 4 and Fig. S7). P1 was 
found to be non-toxic in A549 cells, whereas P2 demonstrated 
significant, but acceptable cytotoxicity on these cells. The 
live/dead fluorescence assay supported this observation with 
the majority of cells remaining alive after 48 hours incubation 
period (Fig. S7). 
Inspired by the rapid and reversible formation of the cell 
aggregates, we tested the possibility of forming macroscopic 
“cellular glues” that could form cell-rich gel type 
Fig. 3 (a) P1-glucose competition assay; gradual reduction of cluster size due to glucose 
concentration increase. (b) Temperature-controlled aggregation of P2-modified HDF 
below and above the LCST of P2 (scale bars = 1 mm). 
Fig. 4 Fluorescence microscopy images of (a) P1 and (b) P2-modified HDF (scale bars = 
500 μm). (c) The effects of P1 and P2 addition on the cellular aggregation kinetics for 
unmodified and modified HDF as a function of time (data shown as mean ± SD from 
three experiments). Effect of polymer concentration on cell viability after 24 hours of 
incubation with polymers P1 and P2 in (d) HDF and (e) A549 cell lines. The data are 
expressed as percentage of cell viability with respect to the control corresponding to 
untreated cells (mean ± SD obtained from triplicates). Asterisks (* p ≤ 0.05) indicate 
values that differ significantly from those measured in the positive control (one-way 
ANOVA test). 
 
Fig. 5 Digital photographs of (a) P1 and (b) P2 forming self-supporting gels (500 x 103 
cells in 200 μL DMEM mixed with 10 mg of P1 or P2) at room temperature. 
Deconstruction of the gels can be easily achieved simply by addition of free glucose in 
P1 gels (c) or by lowering the temperature below the LCST of P2 (d). 
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37-39
 for tissue regeneration or the formation of 
millimetre sized 3D tumoroids
40, 41
 for in vitro modelling 
applications. Strikingly, both copolymers could form 
macroscopic cell-laden gels under physiological conditions 
observable by the naked eye that could be reversibly turned to 
their corresponding sol state either by the addition of glucose 
(in the case of P1) or lowering the temperature (in the case of 
P2), as illustrated in Fig. 5. The gels could remain stable for 
hours without any observable change or any significant 
cytotoxicity on either of the cell lines tested. Rheological 
studies further corroborated the sol-gel type transition of both 
copolymers controlled by their corresponding stimuli (Fig. S8). 
 In conclusion, we have synthesized simple copolymers that 
induce rapid cell aggregation in a fully reversible manner at 
minute concentrations in complete culture medium. We 
anticipate that these polymers will find uses as injectable 
“cellular glues” for in vivo tissue regeneration and cell 
transplantation or in the construction of 3D cell 
spheroid/tumoroid models. 
 This project was supported by the Leverhulme Trust (ECF-
2013-472) and the UCL Excellence Fellowship program (G.P.). 
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